Accessibility Menu
Prestige Consumer Healthcare logo

Prestige Consumer Healthcare(NYSE) PBH

Current Price$48.90
Market Cap$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+176%
5 Year-7%
1 Year-36%
1 Month+6%
Prestige Consumer Healthcare last closing stock price
MetricPriceDate
Last closeUSD 48.942026-07-23
Prestige Consumer Healthcare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.28%USD 50.602026-07-16
1 month+6.28%USD 46.052026-06-23
3 month-16.97%USD 58.942026-04-24
Year to date-20.67%USD 61.692025-12-31
1 year-36.22%USD 76.732025-07-23
3 year-22.31%USD 62.992023-07-24
5 year-6.92%USD 52.582021-07-23
Since inception+176.17%USD 17.752005-02-10

Prestige Consumer Healthcare Financials at a Glance

Market Cap

$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.09B

Net Income (TTM)

$190.30M

EPS (TTM)

$3.91

P/E Ratio

12.51

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$48.90

Volume

16,502

Open

$48.88

Previous Close

$48.90

Daily Range

$48.25 - $49.16

52-Week Range

$42.62 - $77.03

Estimated Earnings Date

Aug 6, 2026

PBH News

GettyImages-658027576

Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy.

Micah ZimmermanJul 3, 2026
Foolcom-Featured.png

Prestige (PBH) Q1 Revenue Falls 6.6%

Motley Fool Markets TeamAug 7, 2025
businessman with coins falling through his hands -- stock loss bear market crash losing money

Why Tailored Brands, Newmont Mining, and Prestige Consumer Healthcare Slumped Today

Dan CaplingerJan 14, 2019
Longview3

Why Prestige Brands, DeVry, and Weatherford International Are Today's 3 Best Stocks

Sean WilliamsApr 25, 2014

Why Prestige Brands Holdings Inc. Shares Soared

Sean WilliamsApr 25, 2014

Why Prestige Brands Holdings Inc. Shares Temporarily Soared

Sean WilliamsApr 15, 2014

Why Prestige Brands Holdings Inc. Shares Lost Their Prestige Today

Alex PlanesFeb 6, 2014

Here's How Prestige Brands Holdings Is Making You So Much Cash

Seth JaysonAug 1, 2013
Page 1

PBH: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prestige Consumer Healthcare

Prestige helps people manage common health issues at home. The company makes brand name items for pain and eye care. These products help families stay comfortable and healthy.

What's in the Medicine Cabinet?

  • North American OTC: Health and personal care products sold in the United States and Canada; accounts for 83.9% of net revenues.
  • International OTC: Brand name products sold in Australia and other global markets; accounts for 16.1% of net revenues.
  • Women's Health: Care items for feminine hygiene and yeast infection relief; includes Summer's Eve and Monistat.
  • Gastrointestinal Care: Solutions for motion sickness and upset stomachs; includes names like Dramamine, Fleet, and Gaviscon.
  • Analgesics: Fast-acting powder treatments for headache and body pain; includes the BC and Goody's lines.

Strategic Moves and New Brands

  • Completed the purchase of Pillar5 Pharma Inc. in 2026 to bring eye care manufacturing in-house.
  • Entered a deal to buy brands like Breathe Right and Dimetapp from Foundation Consumer Brands, LLC in 2027.
  • Acquired international rights for Hydralyte in 2025 to grow the business outside of North America.
  • Launched new items like Summer's Eve Whole Body Deodorant and Fleet Mini Enemas to update existing brands.

What Makes Prestige Different

Prestige operates with a low-cost model by outsourcing most manufacturing and distribution to specialized partners. The company focuses on purchasing established brands and using marketing to grow their market share.

A Look at the Numbers

  • Net income reached $53.9 million in Q4 2026, up 7.6% year-over-year.
  • Total revenue was $281.6 million in Q4 2026, down 5.1% from $296.8 million in Q4 2025.
  • Gross profit fell to $140.9 million in Q4 2026, down 19.8% from the previous year.
  • Free cash flow was $45.4 million in Q4 2026, down 22.2% from $58.4 million in Q4 2025.
  • Major brands represented 83.5% of total revenues for the 2026 fiscal year.

Bottom Line

Prestige has grown by acquiring and updating brand name products for the self-care market. Its focus on a wide range of categories and efficient operations helps it manage shifting retail trends.

AI Generated • May 26, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

890

CEO

Ronald M. Lombardi, MBA, CPA

Website

www.prestigebrands.com

Headquarters

Tarrytown, NY 10591, US

PBH Financials

Key Financial Metrics (TTM)

Gross Margin

53.96%

Operating Margin

28.42%

Net Income Margin

17.48%

Return on Equity

10.29%

Return on Capital

10.55%

Return on Assets

5.36%

Earnings Yield

7.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.37M

Volume

16.50K

Avg. Volume

706.39K

Financials (TTM)

Gross Profit

$587.45M

Operating Income

$309.41M

EBITDA

$331.11M

Operating Cash Flow

$265.41M

Capital Expenditure

-$11.18M

Free Cash Flow

$254.23M

Cash & ST Invst.

$63.87M

Total Debt

$1.05B

Prestige Consumer Healthcare Performance Analysis

Prestige Consumer Healthcare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 1,127,725,0003.8%
20242024-03-31USD 1,125,357,000-0.2%
20252025-03-31USD 1,137,762,0001.1%
20262026-03-31USD 1,088,705,000-4.3%
Prestige Consumer Healthcare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-15.9%
Q22025-09-309.9%
Q32025-12-313.4%
Q42026-03-31-0.6%
Prestige Consumer Healthcare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -1.65N/A
20242024-03-31USD 4.17N/A
20252025-03-31USD 4.292.7%
20262026-03-31USD 3.91-8.8%
Prestige Consumer Healthcare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-5.0%
Q22025-09-30-9.5%
Q32025-12-3112.8%
Q42026-03-3116.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$281.62M

-5.1%

Gross Profit

$140.86M

-19.8%

Gross Margin

50.02%

N/A

Market Cap

$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.60M

N/A

Employees

890

N/A

Net Income

$53.93M

+7.6%

EBITDA

$84.55M

-8.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$63.87M

-34.8%

Total Debt

$1.05B

+0.1%

Accounts Receivable

$191.92M

-1.2%

Inventory

$159.13M

+7.7%

Long Term Debt

$1.03B

-0.3%

Short Term Debt

$12.55M

+47.0%

Return on Assets

5.36%

N/A

Return on Invested Capital

9.03%

N/A

Free Cash Flow

$45.41M

-22.2%

Operating Cash Flow

$50.62M

-18.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZLABZai Lab Limited
$19.68-4.00%
HTFLHeartflow, Inc. Common Stock
$24.61+1.57%
IRONDisc Medicine, Inc.
$75.86+2.07%
PRVAPrivia Health Group, Inc.
$24.97-1.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
INTCIntel
$100.23-0.02%
AALAmerican Airlines Group
$13.56-0.08%

Questions About PBH

What is the current price of Prestige Consumer Healthcare?

Prestige Consumer Healthcare is trading at $48.90 per share.

What is the 52-week range for Prestige Consumer Healthcare?

Over the past 52 weeks, Prestige Consumer Healthcare has traded between $42.62 and $77.03.

How much debt does Prestige Consumer Healthcare have?

As of the most recent reporting period, Prestige Consumer Healthcare reported total debt of $1.05B.

How much cash does Prestige Consumer Healthcare have on hand?

Prestige Consumer Healthcare reported $63.87M in cash and cash equivalents in its most recent financial results.

What is Prestige Consumer Healthcare’s dividend yield?

Prestige Consumer Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services